vimarsana.com

Latest Breaking News On - Lantern pharma company profile - Page 1 : vimarsana.com

Lantern Pharma (LTRN) Set to Announce Quarterly Earnings on Wednesday

Lantern Pharma (NASDAQ:LTRN – Get Free Report) will be posting its quarterly earnings results after the market closes on Wednesday, August 9th. Analysts expect Lantern Pharma to post earnings of ($0.40) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. Lantern […]

Lantern Pharma Inc (NASDAQ:LTRN) Forecasted to Post Q2 2023 Earnings of ($0 40) Per Share

Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating) – Equities researchers at Zacks Small Cap issued their Q2 2023 earnings estimates for Lantern Pharma in a report released on Wednesday, May 10th. Zacks Small Cap analyst J. Vandermosten expects that the company will earn ($0.40) per share for the quarter. The consensus estimate for Lantern Pharma’s […]

Lantern Pharma (LTRN) to Release Quarterly Earnings on Tuesday

Lantern Pharma (NASDAQ:LTRN – Get Rating) will issue its quarterly earnings data after the market closes on Tuesday, May 9th. Parties that are interested in participating in the company’s conference call can do so using this link. Lantern Pharma (NASDAQ:LTRN – Get Rating) last released its earnings results on Monday, March 20th. The company reported […]

Lantern Pharma (NASDAQ:LTRN) Rating Reiterated by EF Hutton Acquisition Co I

EF Hutton Acquisition Co. I reaffirmed their buy rating on shares of Lantern Pharma (NASDAQ:LTRN – Get Rating) in a report issued on Tuesday morning, Benzinga reports. The firm currently has a $11.00 price target on the stock. Lantern Pharma Price Performance Shares of Lantern Pharma stock opened at $4.52 on Tuesday. Lantern Pharma has […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.